34 results on '"Tucciarone M"'
Search Results
2. Clinical features of patients who had two COVID‐19 episodes: a European multicentre case series
- Author
-
Lechien, J. R., primary, Chiesa‐Estomba, C. M., additional, Radulesco, T., additional, Michel, J., additional, Vaira, L. A., additional, Le Bon, S. D., additional, Horoi, M., additional, Falanga, C., additional, Barillari, M. R., additional, Hans, S., additional, Tucciarone, M., additional, and Saussez, S., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy
- Author
-
Torre, G. La, Vito, E. De, Langiano, E., Petta, P., Colarossi, G., Cipriani, L., Tucciarone, M., and Ricciardi, G.
- Published
- 2003
- Full Text
- View/download PDF
4. Successful use of recombinant factor VIIa in a patient with paraneoplastic factor XI inhibitor
- Author
-
DELIOS, G., POLLIO, B., TUCCIARONE, M., AITORO, G., BORCHIELLINI, A., SCHINCO, P., and GIROTTO, M.
- Published
- 2008
5. Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy
- Author
-
Torre, G. La, De vito, E., Langiano, E., Petta, P., Colarossi, G., Cipriani, L., Tucciarone, M., and Ricciardi, G.
- Published
- 2002
6. Extensive pyomyositis of prevertebral muscles after acupuncture: Case report
- Author
-
Tucciarone, M., primary, Taliente, S., additional, Gómez-Blasi Camacho, R., additional, Souviron Encabo, R., additional, and González-Orús Álvarez-Morujo, R., additional
- Published
- 2019
- Full Text
- View/download PDF
7. Polimorfismo allelico nella popolazione dei donatori volontari di CSE iscritti nel registro regionale di Piemonte e Valle d'Aosta
- Author
-
Mele, L., Cagnati, M., Berti, P., Perotti, L., Prucca, M., Rendine, S., Garino, E., Mazzola, G. A., Bertinetto, F., Bongioanni, D., Dametto, E., Berrino, M., Ferrero, N. M., Pagliarino, M., Catapano, P., Colombatto, O., Tucciarone, M., Dall'Omo, A. M., Rizzioli, L., Paolucci, I., Pieri, N., Mangione, A. M., Coucourde, G., and Amoroso, A.
- Published
- 2017
8. Epidemiology of Hepatitis C Virus (HCV) antibodies in blood donors from the province of Latina, Italy
- Author
-
LA TORRE, Giuseppe, DE VITO, E, Langiano, E, Petta, P, Colarossi, G, Cipriani, L, Tucciarone, M, and Ricciardi, G.
- Published
- 2003
9. Successful use of recombinant factor VIIa in a patient with paraneoplastic factor XI inhibitor
- Author
-
DELIOS, G., primary, POLLIO, B., additional, TUCCIARONE, M., additional, AITORO, G., additional, BORCHIELLINI, A., additional, SCHINCO, P., additional, and GIROTTO, M., additional
- Published
- 2007
- Full Text
- View/download PDF
10. Myocardial infarction secondary to carbon monoxide poisoning: an uncommon presentation of a common condition. Case report and review of the literature.
- Author
-
Tucciarone M, Dileo PA, Castro ER, and Guerrero M
- Published
- 2009
- Full Text
- View/download PDF
11. Extensive pyomyositis of prevertebral muscles after acupuncture: Case report.
- Author
-
Tucciarone, M., Taliente, S., Camacho, R. Gómez-Blasi, Encabo, R. Souviron, and González-Orús Álvarez-Morujo, R.
- Subjects
- *
ACUPUNCTURE , *HUMAN anatomy , *MUSCLES , *COMPUTED tomography , *NECK pain , *TORTICOLLIS - Abstract
Introduction: Severe infectious diseases that require surgery after acupuncture therapy are quite rare. There are only a few cases of pyomyositis following acupuncture reported in the literature. This paper presents a case of cervical pyomyositis developed after such treatment. Case presentation: A 36-year-old man presented with swelling and pain in the posterior cervical region as well as high fever and torticollis, after having received three sessions of acupuncture therapy during the preceding weeks aimed to treat his neck stiffness. Ultrasound guided fine needle aspiration (FNA) and contrast-enhanced Computed Tomography (CT) were performed, which showed a large abscess along the paraspinal muscles. The symptoms were resolved after surgical treatment and antibiotherapy. Conclusion: Although highly infrequent, pyomyositis is a probable complication of acupuncture. In order to minimise the risk of complications, strict hygenic precautions and knowledge of the human anatomy are mandatory to decrease the rate of complications of acupuncture. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Clinical features of patients who had two COVID-19 episodes: a European multicentre case series
- Author
-
Thomas Radulesco, Chiara Falanga, Maria Rosaria Barillari, Mihaela Horoi, Luigi Angelo Vaira, Manuel Tucciarone, Carlos M. Chiesa-Estomba, Sven Saussez, Justin Michel, Jerome R. Lechien, Stéphane Hans, S.D. Le Bon, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Service d'Oto-rhino-laryngologie et Chirurgie cervico-faciale [Hôpital de la Conception - APHM], Assistance Publique - Hôpitaux de Marseille (APHM), Lechien, J. R., Chiesa-Estomba, C. M., Radulesco, T., Michel, J., Vaira, L. A., Le Bon, S. D., Horoi, M., Falanga, C., Barillari, M. R., Hans, S., Tucciarone, M., and Saussez, S.
- Subjects
0301 basic medicine ,myalgia ,Male ,Pediatrics ,[SDV]Life Sciences [q-bio] ,severity ,Comorbidity ,030204 cardiovascular system & hematology ,Severity of Illness Index ,SARS‐CoV‐2 ,clinical ,Olfaction Disorders ,Taste Disorders ,0302 clinical medicine ,Olfaction Disorder ,Epidemiology ,Medicine ,First episode ,Brief Report ,Headache ,symptom ,3. Good health ,Europe ,Hospitalization ,Taste disorder ,Female ,medicine.symptom ,Human ,Adult ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Fever ,reinfection ,03 medical and health sciences ,COVID‐19 ,Severity of illness ,Internal Medicine ,Humans ,Series (stratigraphy) ,business.industry ,SARS-CoV-2 ,COVID-19 ,Myalgia ,medicine.disease ,030104 developmental biology ,Dyspnea ,Asthenia ,Immunoglobulin G ,symptoms ,Brief Reports ,business - Abstract
International audience; Objective: To investigate the clinical features of patients who had two demonstrated coronavirus disease 2019 (COVID-19) episodes. Methods: Data of patients with both COVID-19 episodes were recruited from 22 March to 27 December 2020. The following outcomes were studied: epidemiological, comorbidities, prevalence and severity of general and otolaryngological symptom, olfactory, aroma, and gustatory dysfunctions. A comparison between first and second episodes was performed. Results: Forty-five patients reported having two confirmed COVID-19 episodes. The majority of patients had mild infections in both episodes. The second clinical episode was significantly similar to the first. The symptom duration of the second episode was shorter than the first. The occurrence of loss of smell was unpredictable from the first to the second episode. Conclusion: The recurrence of COVID-19 symptoms is associated with a similar clinical picture than the first episode in patients with initial mild-to-moderate COVID episode. The pathophysiological mechanisms underlying the development of second episode remain uncertain and may involve either true reinfection or virus reactivation from sanctuaries.
- Published
- 2021
- Full Text
- View/download PDF
13. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
- Author
-
Lechien, Jerome R., Chiesa‐Estomba, Carlos M., Place, Sammy, Van Laethem, Yves, Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Plzak, Jan, Horoi, Mihaela, Hans, Stéphane, Rosaria Barillari, Maria, Cammaroto, Giovanni, Fakhry, Nicolas, Martiny, Delphine, Ayad, Tareck, Jouffe, Lionel, Hopkins, Claire, Saussez, Sven, Blecic, Serge, De Siati, Daniele R., Leich, Pierre, Souchay, Christel, Rossi, Camelia, Journe, Fabrice, Hsieh, Julien, Ris, Laurence, El Afia, Fahd, Harmegnies, Bernard, Distinguin, Lea, Chekkoury‐Idrissi, Younes, Circiu, Marta, Lavigne, Philippe, Lopez Delgado, Irene, Calvo‐Henriquez, Christian, Falanga, Chiara, Coppee, Frederique, Le Bon, Serge Daniel, Rodriguez, Alexandra, Dequanter, Didier, Cornelis, Jean‐Philippe, Vergez, Sebastien, Koenen, Lukas, Giuditta, Mannelli, Molteni, Gabriele, Tucciarone, Manuel, Radulesco, Thomas, Khalife, Mohamad, Fourneau, Anne‐Francoise, Cherifi, Soraya, Manto, Mario, Michel, Justin, Mannelli, Giuditta, Cantarella, Giovanna, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Assistance Publique - Hôpitaux de Marseille (APHM), Laboratoire Parole et Langage (LPL), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), We would like to thank Bayesia (BayesiaLab?, Chang?, France) for the Network Analysis, Jean-Louis Vincent and Michel Van Haeverbeek for the review of the paper or their useful comments, the heads of the Hospitals, which have been involved in the study, for their help in the rapid conduction of the study and the agreement of ethics committees, the European Press/Media (i.e. Le Monde, La Libre, Le Soir, MediQuality, MedScape, and Le Specialiste) for their help in the spread of the information about the study, and FRMH & UMONS for the grant and the support., Lechien, J. R., Chiesa-Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., Barillari, M. R., Cammaroto, G., Fakhry, N., Martiny, D., Ayad, T., Jouffe, L., Hopkins, C., Saussez, S., Blecic, S., De Siati, D. R., Leich, P., Souchay, C., Rossi, C., Journe, F., Hsieh, J., Ris, L., El Afia, F., Harmegnies, B., Distinguin, L., Chekkoury-Idrissi, Y., Circiu, M., Lavigne, P., Lopez Delgado, I., Calvo-Henriquez, C., Falanga, C., Coppee, F., Le Bon, S. D., Rodriguez, A., Dequanter, D., Cornelis, J. -P., Vergez, S., Koenen, L., Giuditta, M., Molteni, G., Tucciarone, M., Radulesco, T., Khalife, M., Fourneau, A. -F., Cherifi, S., Manto, M., Michel, J., Mannelli, G., and Cantarella, G.
- Subjects
0301 basic medicine ,myalgia ,Male ,medicine ,Original ,[SDV]Life Sciences [q-bio] ,coronavirus ,symptoms ,Disease ,epidemiological ,030204 cardiovascular system & hematology ,patients ,clinical ,Olfaction Disorders ,Taste Disorders ,0302 clinical medicine ,Epidemiology ,Sore throat ,Prevalence ,Nose ,Age Factors ,Headache ,Middle Aged ,3. Good health ,Europe ,medicine.anatomical_structure ,COVID-19 ,Female ,patient ,medicine.symptom ,Symptom Assessment ,Coronavirus Infections ,Sex characteristics ,Adult ,medicine.medical_specialty ,Pneumonia, Viral ,03 medical and health sciences ,Betacoronavirus ,Sex Factors ,Throat ,Internal medicine ,Internal Medicine ,Humans ,Pandemics ,covid‐19 ,rhinorrhea ,business.industry ,SARS-CoV-2 ,Bayes Theorem ,Myalgia ,coronaviru ,030104 developmental biology ,business - Abstract
International audience; Background: The clinical presentation of European patients with mild-to-moderate COVID-19 infection is still unknown. Objective: To study the clinical presentation of COVID-19 in Europe. Methods: Patients with positive diagnosis of COVID-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analysing the relationship between outcomes. Results: A total of 1,420 patients completed the study (962 females, 30.7% of healthcare workers). The mean age of patients was 39.17 ± 12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by 45.4%. The mean duration of COVID-19 symptoms of mild-to-moderate cured patients was 11.5 ± 5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate COVID-19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. Conclusion: The clinical presentation of mild-to-moderate COVID-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate COVID-19 that needs to be recognized as such by the WHO.
- Published
- 2020
- Full Text
- View/download PDF
14. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.
- Author
-
Molteni G, Nocini R, Mattioli F, Nakayama M, Dedivitis RA, Mannelli G, Crosetti E, Chiesa-Estomba CM, Sistiaga-Suarez JA, Giordano L, Galli A, Lionello M, Mercante G, Ralli M, Fermi M, Klein-Rodríguez A, Mayo-Yáñez M, Serafini E, Pirola F, Paderno A, Cambria F, Oridate N, Sano D, Boscolo-Rizzo P, Marcuzzo AV, Parrinello G, Marchi F, Saibene AM, Tucciarone M, Viscasillas G, Zeleník K, Ramos DM, Palacios-Garcia J, Tirelli G, Pellini R, Paludetti G, Galli J, Rossi G, De Vincentiis M, Cernea CR, Spriano G, Bussi M, Peretti G, Succo G, Piazza C, Bertolin A, Kowalski LP, Presutti L, and Sacchetto A
- Subjects
- Humans, Squamous Cell Carcinoma of Head and Neck pathology, Neoplasm Staging, Lymphatic Metastasis pathology, Lymph Node Ratio, Prognosis, Retrospective Studies, Lymph Node Excision, Lymph Nodes pathology, Head and Neck Neoplasms pathology
- Abstract
Introduction: The aim of this study is to assess the impact of lymph node ratio (LNR) and number of positive lymph nodes (NPLN) on mortality and recurrence rates in patients with laryngeal squamous cell carcinoma., Materials and Methods: We conducted a retrospective multicenter international study involving 24 Otorhinolaryngology-Head and Neck Surgery divisions. Disease-specific survival (DSS) and disease-free survival (DFS) were evaluated as the main outcomes. The curves for DSS and DFS according to NPLN and LNR were analyzed to identify significant variations and establish specific cut-off values., Results: 2507 patients met the inclusion criteria. DSS and DFS were significantly different in the groups of patients stratified according to LNR and NPLN. The 5-year DSS and DFS based on LNR and NPLN demonstrated an improved ability to stratify patients when compared to pN staging., Conclusion: Our data demonstrate the potential prognostic value of NPLN and LNR in laryngeal squamous cell carcinoma., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
15. Comprehensive management of paranasal sinus fungus balls: A Young-IFOS consensus statement.
- Author
-
Saibene AM, Allevi F, Calvo-Henriquez C, Dauby N, Dondossola D, Hervochon R, Lechien JR, Lobo-Duro D, Locatello LG, Maniaci A, Mannelli G, Mayo-Yáñez M, Maza-Solano J, Radulesco T, Tan N, Tincati C, Tucciarone M, Vaira LA, and Sowerby L
- Subjects
- Humans, Endoscopy methods, Chronic Disease, Fungi, Sinusitis diagnosis, Sinusitis surgery, Paranasal Sinuses
- Abstract
Background: Paranasal sinus fungus balls (PSFB) are a common form of surgically treatable, noninvasive mycosis. To date, no guidelines have standardized PSFB treatment or management of difficult cases (eg, immunocompromised or fragile patients). The clinical consensus statement presented herein aims to provide a comprehensive management guide to PSFB based on current evidence., Methods: A multidisciplinary, international panel of 19 specialists judged statements in 3 rounds of a modified Delphi method survey. Statements encompassed the following PSFB management issues: definition, diagnostic workup; treatment indications and modalities; and follow-up. Otolaryngologists, maxillofacial surgeons, infectious disease specialists, and transplant physicians were considered the target audience., Results: Among the 23 statements, 7 reached strong consensus and 16 reached consensus. Consensus was reached on the definition, diagnosis, and treatment modalities for PSFB. Postoperative follow-up modalities and scenarios with bacterial superinfection were the most debated issues., Conclusion: Until further data are available, these points provide a framework for the management of PSFB. Moreover, PSFB should be considered a noninvasive mycosis that is not necessarily symptomatic or related to odontogenic conditions. Although diagnosis may be incidental, endoscopy and single imaging (computed tomography or magnetic resonance imaging, with distinctive features) are required for diagnosis, whereas contrast medium would allow for differential diagnosis. Although treatment of PSFB should be considered mandatory before sinus augmentation and is recommended for symptomatic patients, immunosuppressed patients, or patients with planned immunosuppression, watchful waiting could be considered for asymptomatic patients with chronic rhinosinusitis who are provided with appropriate advice and assessment., (© 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.)
- Published
- 2023
- Full Text
- View/download PDF
16. Chronic rhinosinusitis with nasal polyps management in the biologic therapy era: an international YO-IFOS survey.
- Author
-
Maza-Solano J, Biadsee A, Sowerby LJ, Calvo-Hernández C, Tucciarone M, Rocha T, Maniaci A, Saibene AM, Chiesa-Estomba CM, Radulesco T, Metwaly O, Lechien JR, Alobid I, and Locatello LG
- Subjects
- Male, Humans, Female, Steroids therapeutic use, Chronic Disease, Biological Therapy, Nasal Polyps therapy, Nasal Polyps drug therapy, Rhinitis therapy, Rhinitis drug therapy, Sinusitis therapy, Sinusitis drug therapy
- Abstract
Purpose: To investigate the consistency between the international guidelines recommendations and worldwide standard practices regarding diagnostic work-up and follow-up strategies for managing patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the era of monoclonal antibodies., Methods: A questionnaire developed by the Rhinology section of the Young Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies (Yo-IFOS) included items regarding the management of CRSwNP patients, monoclonal prescription, surgical and follow-up procedures, awareness of biologicals availability, and other relevant clinical practices. The online survey was directed to otolaryngologists and distributed in Europe, North America, South America, and the Middle East through otolaryngological and/or rhinological societies., Results: A total of 202 responses were analyzed; the mean participants' age was 45 ± 11 (73% men and 27% women), and 31% were from the United States, Canada 19%, Europe 45%, Middle East and South America 5%. Only 60% of the respondents declared using validated symptoms and endoscopic score systems in their clinical practice. Several practice discrepancies emerged in our cohort, including preferred surgical approach, prescription of preoperative oral steroids, and perioperative antibiotics (59% and 58%, respectively), as well as divergent awareness levels of available biologics for CRSwNP worldwide., Conclusions: CRSwNP needs a complex and time-consuming assessment, according to the latest guidelines. There seems to be a gap between these recommendations and the real-world data, which should draw more attention to bringing them into uniform clinical practice in the near future., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
17. Turbinate surgery in pediatric patients: A worldwide survey.
- Author
-
Calvo-Henriquez C, Tucciarone M, Lechien JR, Maniaci A, Graham E, Maza-Solano J, Metwaly O, Martinez-Capoccioni G, Mariño-Sanchez F, Plaza G, and Martin-Martin C
- Subjects
- Humans, Child, Turbinates surgery, Hypertrophy surgery, Surveys and Questionnaires, Rhinitis surgery, Otolaryngology
- Abstract
Objective: Impaired nasal breathing is a common condition among pediatric patients, being rhinitis the most common cause. In recent years, turbinate surgery, mainly turbinate radiofrequency ablation (TRA), has increased in popularity amongst pediatric otolaryngologists and rhinologists as a safe and useful technique to address turbinate hypertrophy in pediatric patients. The present paper is designed with the aim of assessing the current worldwide clinical practice regarding turbinate surgery in pediatric patients., Methods: The questionnaire was developed based on previous researches, by a group of 12 experts from the rhinology and pediatric otolaryngology research group belonging to the Young Otolaryngologists of the International Federation of Otorhinolaryngological societies (YO-IFOS). The survey was then translated to 7 languages and sent to 25 scientific otolaryngologic societies around the globe., Results: 15 scientific societies agreed to distribute the survey to their members. There were 678 responses from 51 countries. From them, 65% reported to usually perform turbinate surgery in pediatric patients. There was a statistically significant increased likelihood of performing turbinate surgery for those practicing rhinology, sleep medicine, and/or pediatric otolaryngology compared to other subspecialties. The main indication to perform turbinate surgery was nasal obstruction (93.20%); followed by sleep disordered breathing (53.28%), chronic rhinosinusitis (28.70%) and facial growth alterations (22.30%)., Conclusions: There is no general consensus on the indications and ideal technique for turbinate reduction in children. This dissension arises mainly from the lack of scientific evidence. The points with highest agreement (>75%) between respondents is the use of nasal steroids prior to surgery; reintroducing nasal steroids in allergic patients; and performing turbinate surgery as day-case surgery., (Copyright © 2023. Published by Elsevier España, S.L.U.)
- Published
- 2023
- Full Text
- View/download PDF
18. How deep do you go? Clinical prediction of nasopharyngeal depth based on facial measurements.
- Author
-
Dickie A, Rocha T, Maniaci A, Ingrassia A, Maria Saibene A, Spagnolini S, Locatello LG, Tucciarone M, Radulesco T, Rotenberg B, and Sowerby LJ
- Subjects
- Adult, Male, Humans, Female, Middle Aged, Cross-Sectional Studies, Lip, Tomography, X-Ray Computed, Nasopharynx diagnostic imaging, Nose
- Abstract
Nasopharyngeal depth (ND) prediction is clinically relevant in performing medical procedures, and in enhancing technique accuracy and patient safety. Nonetheless, clinical predictive variables and normative data in adults remain limited. This study aimed to determine normative data on ND and its correlation to external facial measurements. A multicenter cross-sectional study obtained data from adults presenting to otolaryngology clinics at five sites in Canada, Italy, and Spain. Investigators compared endoscopically measured depth from the nasal sill (soft tissue between the nasal ala and columella) to nasopharynx along the nasal floor to the "curved distance from the alar-facial groove along the face to the tragus" and "distance from the tragus to a plane perpendicular to the philtrum." When sinus computed tomography images were available, the distance from the nasopharynx to the nasal sill was also collected. 371 patients participated in the study (41% women; 51 years old, SD 18). Average ND was 9.4 cm (SD 0.86) and 10.1 cm (SD 0.9) for women and men, respectively (p < 0.001; 95% CI 0.46-0.86). Perpendicular distance was strongly correlated to ND (r = 0.775; p < 0.001), with an average underestimation of 0.1 cm (SD 0.65; 95% CI 0.06-0.2). The equation: ND (cm) = perpendicular distance*0.773 + 2.344, generated from 271 randomly selected participants, and validated on 100 participants, resulted in a 0.03 cm prediction error (SD 0.61; 95% CI -0.08-0.16). Nasopharyngeal depth can be approximated by the distance from the tragus to a plane perpendicular to the philtrum., (© 2022 American Association of Clinical Anatomists and British Association of Clinical Anatomists.)
- Published
- 2023
- Full Text
- View/download PDF
19. Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis.
- Author
-
Chiesa-Estomba CM, Urazan JD, Cammaroto G, Mannelli G, Molteni G, Dallari V, Lechien JR, Mayo-Yanez M, González-García JÁ, Sistiaga-Suarez JA, Tucciarone M, Ayad T, and Meccariello G
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Lymph Nodes pathology, Lymphatic Metastasis pathology, Neck Dissection methods, Neoplasm Staging, Prospective Studies, Retrospective Studies, Oropharyngeal Neoplasms pathology, Oropharyngeal Neoplasms surgery, Papillomavirus Infections pathology, Squamous Cell Carcinoma of Head and Neck surgery, Squamous Cell Carcinoma of Head and Neck pathology
- Abstract
Introduction: Nowadays, 70% of patients in Europe and the USA are affected by a p16 + , potentially HPV driven oropharyngeal squamous cell carcinoma. However, despite the improved survival rate in this group, the quality-of-life remains low in cases which neck dissection took place. In this vein, in recent years, some surgeons have considered to avoid dissection of level IIB, proposing a supra-selective non-IIb neck dissection., Materials and Methods: A retrospective, longitudinal, multicentric study was conducted, including patients with pathologically confirmed primary HPV + or HPV - OPSCC who went through surgical treatment for the primary lesion and neck dissection., Results: 141 patients were included. Among them, 99 (70.2%) were male and 42 (29.8%) were female. The mean age was 62 ± 9 years (range 36-81). The most frequent anatomical location was the tonsil in 63 (44.7%) of patients. The most common approach was the classic transoral oropharyngectomy in 51 (36.2%) patients. Immunohistochemistry for p16 was positive in 62 (44%) patients. One-hundred and five (74.5%) patients received a unilateral ND, and a 36 (25.5%) a bilateral ND. Of those, a 12.8% (18/141) of patients were level IIb LN + . According to our results, level IIb ND should be considered in patients underwent therapeutic ND with positive LN metastasis in level IIa (OR = 9.83; 95% CI 3.463-27.917) or III (OR = 6.25; 95% CI 2.158-18.143), advanced (T3/T4) oropharyngeal primary tumors (OR = 3.38; 95% CI 1.366-8.405), and patients with ENE (OR = 6.56; 95% CI 2.182-19.770), regardless of p16 status., Conclusions: According to our results, level IIb ND should be considered in patients who underwent therapeutic ND with positive LN metastasis in level IIa or III, advanced oropharyngeal primary tumors, and patients with ENE, independently of p16 status. Prospective data are necessary to definitively ensure the safety of omitting ipsilateral or contralateral level IIb ND in cN - patients with early stage disease., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
20. Correction: Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis.
- Author
-
Chiesa-Estomba CM, Urazan JD, Cammaroto G, Mannelli G, Molteni G, Dallari V, Lechien JR, Mayo-Yanez M, González-García JÁ, Sistiaga-Suarez JA, Tucciarone M, Ayad T, and Meccariello G
- Published
- 2023
- Full Text
- View/download PDF
21. Rates of Intracoronary Imaging Optimization in Contemporary Percutaneous Coronary Intervention: A Report From the BMC2 Registry.
- Author
-
Madder RD, Seth M, Sukul D, Alraies MC, Qureshi M, Tucciarone M, Saltiel F, Qureshi MI, and Gurm HS
- Subjects
- Humans, Coronary Angiography methods, Bayes Theorem, Treatment Outcome, Registries, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention methods, Coronary Artery Disease therapy, Coronary Artery Disease surgery
- Abstract
Background: Intracoronary imaging (ICI) during percutaneous coronary intervention (PCI) improves outcomes, yet hospital- and physician-level variabilities in ICI and its impact on ICI use in contemporary PCI remain unknown. This study was performed to evaluate hospital- and physician-level use of ICI to optimize PCI., Methods: Using data from a large statewide registry, patients undergoing PCI between July 2019 and March 2021 were studied. The primary measure of interest was ICI (intravascular ultrasound or optical coherence tomography) optimization during PCI. A fitted hierarchical Bayesian model identified variables independently associated with ICI optimization. The performing hospital and physician were included as random effects in the model., Results: Among 48 872 PCIs, ICI optimization was performed in 8094 (16.6%). Median [interquartile range] hospital- and physician-level frequencies of ICI were 8.8% [3.1%, 16.0%] and 6.1% [1.1%, 25.0%], respectively. Bayesian modeling identified left main PCI (adjusted odds ratio [aOR], 4.41; 95% credible interval [3.82, 5.10]), proximal left anterior descending artery PCI (aOR, 2.28 [2.00, 2.59]), PCI for in-stent restenosis (aOR, 1.55 [1.40, 1.72]), and surgical consult prior to PCI (aOR, 1.21 [1.07, 1.37]) as independent predictors of ICI optimization. The hospital-level median odds ratio, an estimate of the contribution of inter-hospital variability in odds of ICI use, was 3.48 (2.64, 5.04). Physician-level median odds ratio was 3.81 (3.33, 4.45)., Conclusions: Substantial hospital- and physician-level variation in ICI was observed. Except for performance of left main PCI, the hospital and physician performing the PCI were more strongly associated with ICI optimization than any patient or procedural factors.
- Published
- 2022
- Full Text
- View/download PDF
22. Management of oral feeding following total laryngectomy around the world: YO-IFOS international study.
- Author
-
Benali J, Viljoen G, Ayad T, Gravier-Dumonceau R, Ceccon FP, Tangjaturonrasme N, Saibene AM, Chiesa-Estomba C, Melkane AE, Allen J, Lim CM, Mayo-Yañez M, Tucciarone M, Sargi Z, Mouawad F, Ramirez AT, Magaró M, Michel J, Radulesco T, Giovanni A, Fagan JJ, Hao SP, Lechien JR, Giorgi R, and Fakhry N
- Subjects
- Humans, Laryngectomy, Pharyngectomy, Postoperative Complications, Larynx, Pharyngeal Diseases
- Abstract
Background: To analyze worldwide practices regarding the initiation of oral feeding after total laryngectomy (TL)., Methods: Online survey., Results: Among the 332 responses received, 278 from 59 countries were analyzed. Our results showed that 45.6% of respondents started water and 45.1% started liquid diet between postoperative days 7 and 10. Semi-solid feeds were initiated between days 10 and 14 for 44.9% of respondents and a free diet was allowed after day 15 for 60.8% of respondents. This timing was significantly delayed in cases of laryngo-pharyngectomy and after prior radiotherapy (p < 0.001). A greater proportion of respondents in Africa and Oceania allowed early oral feeding before day 6 as compared with the rest of the world (p < 0.001)., Conclusion: Despite increasing number of publications, there is still a lack of evidence to support early oral feeding. The majority of respondents preferred to delay its initiation until at least 7 days after surgery., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
23. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia.
- Author
-
Lechien JR, Chiesa-Estomba CM, Cabaraux P, Mat Q, Huet K, Harmegnies B, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Hans S, Crevier-Buchman L, Hochet B, Distinguin L, Chekkoury-Idrissi Y, Circiu M, El Afia F, Barillari MR, Cammaroto G, Fakhry N, Michel J, Radulesco T, Martiny D, Lavigne P, Jouffe L, Descamps G, Journe F, Trecca EMC, Hsieh J, Delgado IL, Calvo-Henriquez C, Vergez S, Khalife M, Molteni G, Mannelli G, Cantarella G, Tucciarone M, Souchay C, Leich P, Ayad T, and Saussez S
- Subjects
- Bayes Theorem, Female, Hoarseness, Humans, Male, Prevalence, COVID-19 diagnosis, COVID-19 epidemiology, Dysphonia diagnosis, Dysphonia epidemiology
- Abstract
Introduction: To explore the prevalence of dysphonia in European patients with mild-to-moderate COVID-19 and the clinical features of dysphonic patients., Methods: The clinical and epidemiological data of 702 patients with mild-to-moderate COVID-19 were collected from 19 European Hospitals. The following data were extracted: age, sex, ethnicity, tobacco consumption, comorbidities, general, and otolaryngological symptoms. Dysphonia and otolaryngological symptoms were self-assessed through a 4-point scale. The prevalence of dysphonia, as part of the COVID-19 symptoms, was assessed. The outcomes were compared between dysphonic and nondysphonic patients. The association between dysphonia severity and outcomes was studied through Bayesian analysis., Results: A total of 188 patients were dysphonic, accounting for 26.8% of cases. Females developed more frequently dysphonia than males (P = 0.022). The proportion of smokers was significantly higher in the dysphonic group (P = 0.042). The prevalence of the following symptoms was higher in dysphonic patients compared with nondysphonic patients: cough, chest pain, sticky sputum, arthralgia, diarrhea, headache, fatigue, nausea, and vomiting. The severity of dyspnea, dysphagia, ear pain, face pain, throat pain, and nasal obstruction was higher in dysphonic group compared with nondysphonic group. There were significant associations between the severity of dysphonia, dysphagia, and cough., Conclusion: Dysphonia may be encountered in a quarter of patients with mild-to-moderate COVID-19 and should be considered as a symptom list of the infection. Dysphonic COVID-19 patients are more symptomatic than nondysphonic individuals. Future studies are needed to investigate the relevance of dysphonia in the COVID-19 clinical presentation., (Copyright © 2020 The Voice Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
24. Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.
- Author
-
Saibene AM, Allevi F, Ayad T, Baudoin T, Bernal-Sprekelsen M, Briganti G, Carrie S, Cayé-Thomasen P, Dahman Saidi S, Dauby N, Fenton J, Golusiński W, Klimek L, Leclerc AA, Longtin Y, Mannelli G, Mayo-Yáñez M, Meço C, Metwaly O, Mouawad F, Niemczyk K, Pedersen U, Piersiala K, Plzak J, Remacle M, Rommel N, Saleh H, Szpecht D, Tedla M, Tincati C, Tucciarone M, Zelenik K, and Lechien JR
- Subjects
- Breast Feeding, Consensus, Female, Humans, Male, Pregnancy, SARS-CoV-2, Vaccination, COVID-19, COVID-19 Vaccines, Otolaryngologists, Surgeons
- Abstract
Purpose: SARS-CoV-2 vaccines are a key step in fighting the pandemic. Nevertheless, their rapid development did not allow for testing among specific population subgroups such as pregnant and breastfeeding women, or elaborating specific guidelines for healthcare personnel working in high infection risk specialties, such as otolaryngology (ORL). This clinical consensus statement (CCS) aims to offer guidance for SARS-CoV-2 vaccination to this high-risk population based on the best evidence available., Methods: A multidisciplinary international panel of 33 specialists judged statements through a two-round modified Delphi method survey. Statements were designed to encompass the following topics: risk of SARS-Cov-2 infection and use of protective equipment in ORL; SARS-Cov-2 infection and vaccines and respective risks for the mother/child dyad; and counseling for SARS-CoV-2 vaccination in pregnant, breastfeeding, or fertile healthcare workers (PBFHW). All ORL PBFHW were considered as the target audience., Results: Of the 13 statements, 7 reached consensus or strong consensus, 2 reached no consensus, and 2 reached near-consensus. According to the statements with strong consensus otorhinolaryngologists-head and neck surgeons who are pregnant, breastfeeding, or with childbearing potential should have the opportunity to receive SARS-Cov-2 vaccination. Moreover, personal protective equipment (PPE) should still be used even after the vaccination., Conclusion: Until prospective evaluations on these topics are available, ORL-HNS must be considered a high infection risk specialty. While the use of PPE remains pivotal, ORL PBFHW should be allowed access to SARS-CoV-2 vaccination provided they receive up-to-date information., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
25. Lobular Capillary Hemangioma of the External Jugular Vein: A Rare Case Report.
- Author
-
Tucciarone M, López-Flórez L, Martínez-Guirado T, Souviron-Encabo R, and Álvarez-Morujo RG
- Abstract
Introduction: Hemangiomas are benign tumors that are very common in the head and neck region. However, intravascular hemangiomas are very rare. Hemangiomas are classified as capillary, cavernous or mixed tumors according to the proliferating cells. Ultrasound, computed tomography, MR imaging and angiography are useful diagnostic tools and are generally required when planning surgical treatment. Definitive diagnosis is established by histopathological examination, differentiating hemangiomas from other vascular tumors or malignancies., Case Report: We present a rare case of capillary hemangioma protruding from the external jugular vein. In our patient, the tumor was totally removed under local anesthesia. No complications and no recurrence were observed in the following two years., Conclusion: Intravascular tumors can present as neck masses and a definitive diagnosis is made by histopathological examination. Imaging tools provide important information about anatomy, the extent of the tumor, and for surgical planning.
- Published
- 2021
- Full Text
- View/download PDF
26. Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
- Author
-
Gurm Z, Seth M, Daher E, Pielsticker E, Qureshi MI, Zainea M, Tucciarone M, Hanzel G, Henke PK, and Sukul D
- Subjects
- Adult, Age Factors, Aged, Coronary Disease etiology, Coronary Disease surgery, Female, Humans, Male, Michigan epidemiology, Middle Aged, Obesity epidemiology, Prevalence, Sex Factors, Smoking epidemiology, Coronary Disease prevention & control, Heart Disease Risk Factors, Percutaneous Coronary Intervention statistics & numerical data, Primary Prevention methods
- Abstract
Background: Cigarette smoking, hypertension, dyslipidemia, diabetes, and obesity are conventional risk factors (RFs) for coronary artery disease (CAD). Population trends for these RFs have varied in recent decades. Consequently, the risk factor profile for patients presenting with a new diagnosis of CAD in contemporary practice remains unknown., Objectives: To examine the prevalence of RFs and their temporal trends among patients without a history of myocardial infarction or revascularization who underwent their first percutaneous coronary intervention (PCI)., Methods: We examined the prevalence and temporal trends of RFs among patients without a history of prior myocardial infarction, PCI, or coronary artery bypass graft surgery who underwent PCI at 47 non-federal hospitals in Michigan between 1/1/2010 and 3/31/2018., Results: Of 69,571 men and 38,930 women in the study cohort, 95.5% of patients had 1 or more RFs and nearly half (55.2% of women and 48.7% of men) had ≥3 RFs. The gap in the mean age at the time of presentation between men and women narrowed as the number of RFs increased with a gap of 6 years among those with 2 RFs to <1 year among those with 5 RFs. Compared with patients without a current/recent history of smoking, those with a current/recent history of smoking presented a decade earlier (age 56.8 versus 66.9 years; p <0.0001). Compared with patients without obesity, patients with obesity presented 4.0 years earlier (age 61.4 years versus 65.4 years; p <0.0001)., Conclusions: Modifiable RFs are widely prevalent among patients undergoing their first PCI. Smoking and obesity are associated with an earlier age of presentation. Population-level interventions aimed at preventing obesity and smoking could significantly delay the onset of CAD and the need for PCI., Competing Interests: Dr. Devraj Sukul and Mr. Milan Seth receive salary support from the Blue Cross Blue Shield of Michigan (BCBSM) for their work in BMC2. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors do not have any direct conflicts or competing interest that could affect the study or its data presentation. The opinions, beliefs and viewpoints expressed by the authors do not necessarily reflect those of BCBSM or any of its employees.
- Published
- 2021
- Full Text
- View/download PDF
27. Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms.
- Author
-
Lechien JR, Chiesa-Estomba CM, Hans S, Calvo-Henriquez C, Mayo-Yáñez M, Tucciarone M, Vaira LA, Saussez S, and Saibene AM
- Subjects
- Adult, Case-Control Studies, Fatigue etiology, Female, Headache etiology, Humans, Male, Myalgia etiology, Reproducibility of Results, COVID-19 diagnosis, Severity of Illness Index, Symptom Assessment
- Abstract
Background: There is no clinical instrument evaluating symptoms of COVID-19., Objective: To develop a clinical instrument for evaluating symptoms of COVID-19 mild-to-moderate forms., Methods: COVID-19 patients were recruited from EpiCURA Hospital (Belgium). They completed the COVID-19 Symptom Index (CSI) twice to assess the test-retest reliability. The internal consistency was evaluated with Cronbach's alpha. CSI was completed by healthy subjects to assess the internal validity. Patients completed CSI 6 weeks after the COVID-19 resolution to evaluate the responsiveness to change., Results: Ninety-four COVID-19 patients and 55 healthy individuals completed the evaluations. Symptoms associated with the higher severity score were fatigue, headache and myalgia. The Cronbach's alpha value was 0.801, indicating high internal consistency. The test-retest reliability was adequate (r
s = 0.535, p = .001). The correlation between CSI total score and SNOT-22 was high (rs = 0.782; p < .001), supporting a high external validity. COVID-19 patients reported significant higher CSI score than healthy individuals, suggesting an adequate internal validity. The mean CSI significantly decreased after the COVID-19 resolution, supporting a high responsiveness to change property., Conclusion and Significance: The CSI is a reliable and valid patient reported outcome questionnaire for the evaluation of symptom severity of COVID-19 patients.- Published
- 2021
- Full Text
- View/download PDF
28. Translation and validation of the short version of the Questionnaire of Olfactory Disorders-Negative Statements to Spanish.
- Author
-
Chiesa-Estomba CM, Lechien JR, Calvo-Henríquez C, Mayo M, Maldonado B, Maza J, Tucciarone M, Villareal I, Vaira LA, Izquierdo-Dominguez A, and Alobid I
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19 epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Olfaction Disorders etiology, Reproducibility of Results, Surveys and Questionnaires, Young Adult, COVID-19 complications, Language, Olfaction Disorders diagnosis, Translations
- Abstract
Introduction: There are more than 400 million of native Spanish speakers around the world, being the second most spoken language in regard to the number of native speakers. For this reason, a valid questionnaire to access the olfaction of our patients is necessary., Material and Methods: Validation and cross-cultural adaptation of the svQOD-NS questionnaire to the Spanish language. Internal consistency of svQOD-NS measured with Cronbach α., Results: 40 patients met the inclusion criteria. 41 ± 153 (range 21-82), and 32 (80%) were female. 20 patients (57,1%) were male and 15 (42,9%) were female. There was a normal distribution among patients included according to the Shapiro-Wilk test (p = 0.175). Internal consistency of svQOD-NS measured with Cronbach α was 0.861. The intraclass correlation coefficient was 0.849 (confidence interval [CI] 95%: 0.766-0.911)., Conclusion: The Spanish Language is the second most spoken language with regard to the number of native speakers and the svQOD-NS translation represents a valid option for the Spanish-speaking medical community, from which a large number of patients can benefit., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
29. A giant pseudoaneurysm mimicking a parapharyngeal abscess.
- Author
-
Tucciarone M, Elvira Ruiz P, and González-Orus Álvarez-Morujo RJ
- Published
- 2020
- Full Text
- View/download PDF
30. Salvage total laryngectomy: is a flap necessary?
- Author
-
Gonzalez-Orús Álvarez-Morujo R, Martinez Pascual P, Tucciarone M, Fernández Fernández M, Souviron Encabo R, and Martinez Guirado T
- Subjects
- Adult, Aged, Aged, 80 and over, Cutaneous Fistula surgery, Female, Humans, Male, Middle Aged, Neoplasm Staging, Postoperative Complications, Retrospective Studies, Risk Factors, Severity of Illness Index, Cutaneous Fistula etiology, Laryngeal Neoplasms surgery, Laryngectomy adverse effects, Surgical Flaps transplantation
- Abstract
Introduction: Pharyngocutaneous fistula is the most significant complication after salvage total laryngectomy in patients who have received previous treatment with radiotherapy with or without chemotherapy., Objective: Our purpose is to review the fistula rate in radiated patients undergoing salvage total laryngectomy, to determine if the use of pectoralis major flap interposition reduces the incidence and duration of fistula and to examine other risk factors., Methods: We made a retrospective review of patients undergoing salvage total laryngectomy for exclusively larynx cancer after failure of primary curative radiotherapy between 2000 and 2017. General data from patients, risk factors and other complications were analyzed., Results: We identified 27 patients whose mean age was 66.4 years, mainly male (92.5%). The primary closure group without pectoralis major flap included 14 patients, and the group with pectoralis major flap closure included 13 patients. Pharyngocutaneous fistula was present in 15 patients (55.5%). Global pharyngocutaneous fistula rate was higher in the group of patients without pectoralis major flap comparing with those were the flap was interposed (78.6% versus 30.8%, p=0.047). Also the pharyngocutaneous fistulas which need to be repaired with surgery (64.3% versus 7.7%, p=0.03) and large pharyngostomes (64.3% versus 0%, p=0.0004) were present in a higher rate in the group closed primary without pectoralis major flap. We did not find other risk factors with statistical significance. Oral diet initiation (84 days versus 21.5 days, p=0.039) and the duration of hospitalization (98.3 days versus 27.2 days, p=0.0041) were much lower in patients with a preventive pectoralis major flap. Two patients died as a consequence of complications of large pharyngostomes., Conclusions: Prophylactic pectoralis major flap reduced the incidence, severity and duration of fistula and should be considered during salvage total laryngectomy., (Copyright © 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
31. Giant Thyroid Fibrosarcoma- A Case Report.
- Author
-
Tucciarone M, Heredia-Llinas C, Lowy-Benoliel A, Souviron-Encabo R, Martínez-Guirado T, and Álvarez-Morujo RG
- Abstract
Introduction: Thyroid gland fibrosarcomas are extremely rare tumors, and only very few cases have been described in the literature. There are no set recommendations along with follow-ups regarding the treatment of these tumors. Moreover, the prognosis is poor with a very short life expectancy., Case Report: We present an 81-year-old patient who was suffering from increasing dysphagia and dysphonia related to a painless giant cervical mass, which presented with progressive growth for the preceding months. After a core needle biopsy with a suspicion of a solitary fibrous tumor, total excision of the tumor was successfully performed, and the pathology examination revealed a fibrosarcoma. Following surgery, radiotherapy was decided in the oncological multidisciplinary meeting; however, the patient refused it. There were neither new clinical symptoms nor tumor recurrence after an 18-month follow-up., Conclusion: Although it is a very rare tumor, primary fibrosarcoma of the thyroid gland should be kept in mind in the differential diagnosis of neck tumors.
- Published
- 2020
- Full Text
- View/download PDF
32. Primary and Secondary Vascular Access Site Complications Associated With Percutaneous Coronary Intervention: Insights From the BMC2 Registry.
- Author
-
Kopin D, Seth M, Sukul D, Dixon S, Aronow HD, Lee D, Tucciarone M, Pielsticker E, and Gurm HS
- Subjects
- Aged, Catheterization, Peripheral trends, Female, Humans, Incidence, Male, Michigan epidemiology, Middle Aged, Percutaneous Coronary Intervention trends, Practice Patterns, Physicians', Prevalence, Punctures, Registries, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Vascular Diseases diagnostic imaging, Vascular Diseases therapy, Catheterization, Peripheral adverse effects, Femoral Artery diagnostic imaging, Percutaneous Coronary Intervention adverse effects, Radial Artery diagnostic imaging, Vascular Diseases epidemiology
- Abstract
Objectives: This study sought to describe the association between trends in primary and secondary vascular access sites and vascular access site complications (VASCs) among patients who underwent percutaneous coronary intervention (PCI) in Michigan., Background: The frequency of transradial PCI has increased. As a result, there is concern that operators may lose femoral-access proficiency resulting in a paradoxical increase in PCI complications. Anecdotally, an increase in secondary access use during PCI has also been observed., Methods: Data from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry was queried to evaluate the use of transradial and transfemoral PCI and their associated VASCs., Results: From 2013 to 2017, transradial PCI increased from 25.9% to 45.2% and the overall use of secondary vascular access increased from 4.9% to 8.7% with minimal change in overall VASCs (1.2% to 1.4%). The use of secondary vascular access was associated with increased VASCs (odds ratio [OR]: 5.82; 95% confidence interval [CI]: 5.26 to 6.43). Although, patients treated by operators in the highest tertile of radial use were more likely to experience femoral VASCs (adjusted OR: 1.51; 95% CI: 1.08 to 2.13), treatment by these operators was associated with an overall reduction in all VASCs (adjusted OR: 0.62; 95% CI: 0.46 to 0.83)., Conclusions: Despite increased use of transradial PCI, there has been no significant decrease in VASCs. This is in part attributable to an increased incidence of femoral VASCs and increasing use of secondary vascular access. An overall reduction in VASCs was observed in the highest radial use operators. Further strategies are needed to reduce VASCs in the transradial era., (Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
33. Race and epicardial fat: the impact of anthropometric measurements, percent body fat and sex.
- Author
-
Salami SS, Tucciarone M, Bess R, Kolluru A, Szpunar S, Rosman H, and Cohen G
- Subjects
- Adult, Analysis of Variance, Body Mass Index, Echocardiography, Female, Humans, Male, Middle Aged, Multivariate Analysis, Prospective Studies, Sex Factors, Waist Circumference, Adiposity ethnology, Black People, Pericardium diagnostic imaging, White People
- Abstract
Objective: Epicardial fat is known to be thicker in White men than in Black men. The impact of sex, % body fat, and other anthropometric measures on epicardial fat thickness has not been described. Therefore we sought to evaluate how the racial differences in epicardial fat thickness would differ by these factors., Methods: We used two-dimensional transthoracic echocardiography to measure the epicardial fat thickness in 150 patients who were admitted to our clinical decision unit for chest pain. Standard anthropometric measurements were performed and body mass index (BMI) and % body fat were calculated. Data were analyzed using analysis of variance and multiple regression., Results: Epicardial fat measured at the mid right ventricular wall was significantly greater in Whites than Blacks (4.9 +/- 2.1 mm vs 3.8 +/- 1.8 mm, for males, and 5.8 +/- 3.2 mm vs 3.7 +/- 1.7 mm, for females). The results from regression analysis showed that after controlling for age, sex, BMI and waist circumference, race remained a significant predictor of epicardial fat, with Whites having higher amounts of fat than Blacks. The difference by race remained even after controlling for % body fat, which was also a significant predictor., Conclusion: Anterior epicardial fat thickness is greater in White than Black men and women of the same race and is independent of anthropometric measurements and % body fat. Race may be an important consideration when analyzing the relationship between epicardial fat and cardiovascular risk.
- Published
- 2013
34. Late stent thrombosis secondary to carbon monoxide poisoning.
- Author
-
Dileo PA, Tucciarone M, Castro ER, and Guerrero M
- Subjects
- Angioplasty, Balloon, Coronary adverse effects, Cardiovascular Agents administration & dosage, Coronary Angiography, Coronary Occlusion diagnostic imaging, Coronary Occlusion therapy, Female, Humans, Middle Aged, Occupational Exposure, Sirolimus administration & dosage, Thrombosis diagnostic imaging, Thrombosis therapy, Time Factors, Treatment Outcome, Angioplasty, Balloon, Coronary instrumentation, Carbon Monoxide Poisoning complications, Coronary Occlusion etiology, Drug-Eluting Stents, Thrombosis etiology
- Abstract
Carbon monoxide poisoning has a variety of deleterious cardiac effects including arrhythmias, coronary spasm and myocardial infarction. The pro-thrombotic effect of carbon monoxide poisoning is one of the important postulated mechanisms of cardiac injury. There are multiple case reports of myocardial infarction secondary to carbon monoxide poisoning. However, there is no published case of carbon-monoxide-poisoning-induced stent thrombosis. We present a 50-year-old female with late stent thrombosis of a sirolimus-eluting stent secondary to acute carbon monoxide poisoning., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.